Back
Rapt Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
RAPT
Rapt Therapeutics, Inc.
Last Price:
$35.45
Seasonality Move:
-17.25%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.
Rapt Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.6 | Buy |
| 20-day SMA: | 33.74 | Buy |
| 50-day SMA: | 30.92 | Buy |
| 200-day SMA: | 16.24 | Buy |
| 8-day EMA: | 21.99 | Buy |
| 20-day EMA: | 11.38 | Buy |
| 50-day EMA: | 5.09 | Buy |
| 200-day EMA: | 1.35 | Buy |
Rapt Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.72 | Buy |
| Relative Strength Index (14 RSI): | 62.06 | Buy |
| Chaikin Money Flow: | 183094 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.63 - 35.51) | Buy |
| Bollinger Bands (100): | (15 - 32.76) | Buy |
Rapt Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rapt Therapeutics, Inc. Stock
Is Rapt Therapeutics, Inc. Stock a Buy?
-
Rapt Therapeutics, Inc. share price is 36.47 while RAPT 8-day simple moving average is 34.60, which is a Buy signal.
-
The stock price of RAPT is 36.47 while Rapt Therapeutics, Inc. 20-day SMA is 33.74, which makes it a Buy.
-
Rapt Therapeutics, Inc. 50-day simple moving average is 30.92 while RAPT share price is 36.47, making it a Buy technically.
-
RAPT stock price is 36.47 and Rapt Therapeutics, Inc. 200-day simple moving average is 16.24, creating a Buy signal.
RAPT Technical Analysis vs Fundamental Analysis
Sell
47
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy or a Sell?
-
Rapt Therapeutics, Inc. stock is rated a SellThe current Rapt Therapeutics, Inc. [RAPT] share price is $36.47. The Score for RAPT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Rapt Therapeutics, Inc. Stock Info
Market Cap:
603.1M
Price in USD:
36.47
Share Volume:
558.1K
Rapt Therapeutics, Inc. 52-Week Range
52-Week High:
42.39
52-Week Low:
5.67
Sell
47
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Rapt Therapeutics, Inc. Share Price Forecast
-
What is the Rapt Therapeutics, Inc. stock price today?The Rapt Therapeutics, Inc. stock price is 36.47 USD today.
-
Will RAPT stock go up or go down?Rapt Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Rapt Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rapt Therapeutics, Inc. is overvalued.
Is Rapt Therapeutics, Inc. Stock a Buy?
-
Rapt Therapeutics, Inc. share price is 36.47 while RAPT 8-day exponential moving average is 21.99, which is a Buy signal.
-
The stock price of RAPT is 36.47 while Rapt Therapeutics, Inc. 20-day EMA is 11.38, which makes it a Buy.
-
Rapt Therapeutics, Inc. 50-day exponential moving average is 5.09 while RAPT share price is 36.47, making it a Buy technically.
-
RAPT stock price is 36.47 and Rapt Therapeutics, Inc. 200-day simple moving average is 1.35, creating a Buy signal.
Fundamental Analysis of Rapt Therapeutics, Inc.
Is Rapt Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.70 per share, and a decrease next year of $0.65 per share.
Technical Analysis of Rapt Therapeutics, Inc.
Should I short Rapt Therapeutics, Inc. stock?
-
RAPT Moving Average Covergence Divergence (MACD) indicator is 7.72, suggesting Rapt Therapeutics, Inc. is a Buy
-
Rapt Therapeutics, Inc. Relative Strength Index (RSI) is 62.06, which suggest Rapt Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Rapt Therapeutics, Inc. is (29.63 - 35.51), which suggest Rapt Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Rapt Therapeutics, Inc. is (15 - 32.76), which suggest Rapt Therapeutics, Inc. is a Buy
* Rapt Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.